CompanyHealthHardware
Procyrion, Inc.
Procyrion, Inc. is a Houston-based medical device company developing Aortix, a catheter-delivered percutaneous mechanical circulatory support (pMCS) pump. About the width of a pencil, Aortix is anchored in the descending aorta where it unloads the failing heart while boosting blood flow to the kidneys, targeting acute decompensated heart failure and cardiorenal syndrome. The device holds FDA Breakthrough Device Designation and is in the DRAIN-HF pivotal IDE trial after closing a $57.7M Series E in February 2024.
2005Founded
HoustonHQ
$57.7MSeries E
medical devicescirculatory supportheart failureaortixpercutaneous pumpcardiorenal syndrome
